Evolus, Inc. (EOLS)
USD 9.36
(-8.59%)
USD 9.36
(-8.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.99 Million USD | -41.66% |
| 2022 | 18.85 Million USD | 969.92% |
| 2021 | 1.76 Million USD | -47.47% |
| 2020 | 3.35 Million USD | -47.65% |
| 2019 | 6.4 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 11.54 Million USD | 4.99% |
| 2024 Q2 | 13.38 Million USD | 15.88% |
| 2023 Q3 | 17.62 Million USD | -11.24% |
| 2023 Q2 | 19.85 Million USD | -15.2% |
| 2023 Q4 | 10.99 Million USD | -37.6% |
| 2023 Q1 | 23.41 Million USD | 24.22% |
| 2023 FY | 10.99 Million USD | -41.66% |
| 2022 Q2 | 12.28 Million USD | 239.94% |
| 2022 Q4 | 18.85 Million USD | -12.58% |
| 2022 Q1 | 3.61 Million USD | 105.16% |
| 2022 FY | 18.85 Million USD | 969.92% |
| 2022 Q3 | 21.56 Million USD | 75.48% |
| 2021 Q1 | 2.77 Million USD | -17.26% |
| 2021 FY | 1.76 Million USD | -47.47% |
| 2021 Q4 | 1.76 Million USD | -53.83% |
| 2021 Q3 | 3.81 Million USD | 14.35% |
| 2021 Q2 | 3.33 Million USD | 20.25% |
| 2020 FY | 3.35 Million USD | -47.65% |
| 2020 Q3 | 4.87 Million USD | -52.91% |
| 2020 Q4 | 3.35 Million USD | -31.14% |
| 2020 Q1 | 12.54 Million USD | 95.75% |
| 2020 Q2 | 10.34 Million USD | -17.53% |
| 2019 Q4 | 6.4 Million USD | -36.2% |
| 2019 Q2 | 11.52 Million USD | 346.94% |
| 2019 FY | 6.4 Million USD | 0.0% |
| 2019 Q1 | 2.57 Million USD | 0.0% |
| 2019 Q3 | 10.04 Million USD | -12.84% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -7.76% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 90.109% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -62.476% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 89.461% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -91.778% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -91.778% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -488.239% |
| Alpha Teknova, Inc. | 11.59 Million USD | 5.141% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 65.984% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | 79.362% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 83.241% |
| Cosmos Health Inc. | 4.78 Million USD | -129.649% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1258.185% |
| Embecta Corp. | 152.1 Million USD | 92.769% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 5.572% |
| Procaps Group, S.A. | 96.83 Million USD | 88.642% |
| Theratechnologies Inc. | 6.06 Million USD | -81.306% |
| Harrow Health, Inc. | 10.86 Million USD | -1.205% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -304.487% |
| Biofrontera Inc. | 10.9 Million USD | -0.825% |
| DURECT Corporation | 2.21 Million USD | -395.629% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 85.792% |
| Cronos Group Inc. | 30.33 Million USD | 63.75% |
| OptiNose, Inc. | 8.05 Million USD | -36.587% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1099799900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -92.98% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 61.073% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -310.816% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -138.601% |
| Radius Health, Inc. | 278.64 Million USD | 96.053% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -228.96% |
| ProPhase Labs, Inc. | 3.84 Million USD | -186.332% |
| Phibro Animal Health Corporation | 265.91 Million USD | 95.864% |
| Procaps Group S.A. | 96.83 Million USD | 88.642% |
| Alvotech | 74.43 Million USD | 85.224% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.683% |
| Rockwell Medical, Inc. | 5.87 Million USD | -87.328% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 12.942% |
| SIGA Technologies, Inc. | 64.21 Million USD | 82.874% |
| Tilray Brands, Inc. | 252.08 Million USD | 95.637% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 72.491% |
| Shineco, Inc. | 1.58 Million USD | -592.34% |
| PetIQ, Inc. | 159.3 Million USD | 93.096% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 7298.68% |
| Incannex Healthcare Limited | -10.01 Million USD | 209.815% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 71.285% |
| Alimera Sciences, Inc. | 1.87 Million USD | -485.311% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 70.817% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -582.94% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -145.327% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4223.929% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -5.954% |
| Hempacco Co., Inc. | 2.54 Million USD | -332.545% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 85.224% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 76.989% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 82.823% |
| Currenc Group, Inc. | 732.91 Thousand USD | -1400.591% |
| Kamada Ltd. | 87.74 Million USD | 87.466% |
| Indivior PLC | 141.79 Million USD | 92.244% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -2182.5% |
| Flora Growth Corp. | 8.5 Million USD | -29.267% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4223.929% |
| HUTCHMED (China) Limited | 50.25 Million USD | 78.117% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 89.608% |
| Akanda Corp. | 1.28 Million USD | -754.616% |